Diacrin, Inc.
24Patents
0Active
24Granted
33Portfolio score
Filing activity: Apr 20, 1994 → Aug 17, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5919449A | Porcine cardiomyocytes and their use in treatment of insufficient cardiac function | Human Necessities | 45 | Expired |
| US6432711B1 | Embryonic stem cells capable of differentiating into desired cell lines | Chemistry; Metallurgy | 39 | Expired |
| US6096537A | Cells with multiple altered epitopes on a surface antigen for use in transplantation | Chemistry; Metallurgy | 37 | Expired |
| US6444205B2 | Transplantation of neural cells for the treatment of chronic pain or spasticity | Human Necessities | 33 | Expired |
| US5543316A | Injectable culture medium for maintaining viability of myoblast cells | Human Necessities | 30 | Expired |
| US6140116A | Isolated and modified porcine cerebral cortical cells | Chemistry; Metallurgy | 27 | Expired |
| US6610288B1 | Porcine hepatocytes for use in treatment of disorders characterized by insufficient liver function | Emerging Cross-Sectional Technologies | 27 | Expired |
| US5679340A | Cells with multiple altered epitopes on a surface antigen for use in transplantation | Chemistry; Metallurgy | 26 | Expired |
| US6258353A | Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases | Emerging Cross-Sectional Technologies | 24 | Expired |
| US6284245A | Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders | Human Necessities | 19 | Expired |
| US6294383A | Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases | Emerging Cross-Sectional Technologies | 16 | Expired |
| US6204053A | Porcine cortical cells and their use in treatment of neurological deficits due to neurodegenerative diseases | Chemistry; Metallurgy | 15 | Expired |
| US6277372A | Porcine neural cells and their use in treatment of neurological deficits due to neurodegenerative diseases | Chemistry; Metallurgy | 12 | Expired |
| US5837236A | Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity | Human Necessities | 12 | Expired |
| US5593673A | Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity | Human Necessities | 11 | Expired |
| US6517833B2 | Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders | Human Necessities | 11 | Expired |
| US6673604B1 | Muscle cells and their use in cardiac repair | Chemistry; Metallurgy | 8 | Expired |
| US5629194A | Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity | Human Necessities | 7 | Expired |
| US5677174A | Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity | Human Necessities | 7 | Expired |
| US5961972A | Isolated porcine pancreatic cells for use in treatment of diseases characterized by insufficient insulin activity | Human Necessities | 5 | Expired |
| US6521448B1 | Porcine MHC class I genes and uses thereof | Human Necessities | 4 | Expired |
| US6491912B2 | Porcine cardiomyocytes and their use in treatment of insufficient cardiac function | Human Necessities | 4 | Expired |
| US6821779B1 | Methods for storing neural cells | Emerging Cross-Sectional Technologies | 3 | Expired |
| US6713245B2 | Methods for storing neural cells such that they are suitable for transplantation | Emerging Cross-Sectional Technologies | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.